Cancer antigen 15-3 (CA 15.3)

Reference

Reference
Dittadi R, Peloso L and Gion M, 2008, Ann Clin Biochem, 45, 226-8 , Witin-subject biological variation in disease: the case of tumour markers

Scoring

Total Score

C6,10,12

Parameter Score
1. Scale A
2. Study Population A
3. Samples B
4. Measurand A
5. Pre-Analytical A
6. Replicate Analysis C
7. Steady State B
8. Outlier Analysis A
9. Normality B
10. Variance Homogeneity C
11. ANOVA A
12. CI C
13. No of Results A
14. Concentrations A
15. Total Score C6,10,12
Comment C6,10, 12

Item Details

Parameter Score
Matrix Unknown
Measurand Cancer antigen 15-3 (CA 15.3)
Unit ug / L
Overall Analytical Principle Method Immunoassay; Not specified
Number of Subjects 21
Number of Subjects included in BV estimation 21
Ethinicity Caucasian
Age Mean / Median 50.5
Age Min 41.0
Age Max 60.0
Age SD
Number of Males 0
Number of Females 21
State of Well Being
Non-healthy (excl pregnant)
Diseases
Study Duration Length 6
Study Duration Units Month
Sampling Intervals, e.g. X sample(s) per Interval Unit 1
Interval Units Month
Sampling Times Start Time:
End Time:
Number of Samples 6
Average Number of Samples Used for BV Estimation 6.0
Average Number of Replicates 2.0
Estimates of CVi 17.3
Calculated Confidence Intervals of CVi Lower: , Upper:
Estimates of CVg
Calculated Confidence Intervals of CVg Lower: , Upper:
Analytical CV
Calculated Confidence Intervals of Analytical CV Lower: , Upper:
Measurand Mean
Measurand Min 7.3
Measurand Max 25.7
Measurand SD

Coding